Tamoxifen-induced reduction in mammographic density and breast cancer risk reduction: a nested case-control study.
Authors
Cuzick, JackWarwick, Jane
Pinney, Elizabeth
Duffy, Stephen W
Cawthorn, Simon
Howell, Anthony
Forbes, John F
Warren, Ruth M L
Affiliation
Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK. j.cuzick@qmul.ac.ukIssue Date
2011-05-04
Metadata
Show full item recordAbstract
Mammographic breast density is a strong risk factor for breast cancer. Tamoxifen, which reduces the risk of breast cancer in women at high risk, also reduces mammographic breast density. However, it is not known if tamoxifen-induced reductions in breast density can be used to identify women who will benefit the most from prophylactic treatment with this drug.Citation
Tamoxifen-induced reduction in mammographic density and breast cancer risk reduction: a nested case-control study. 2011, 103 (9):744-52 J Natl Cancer InstJournal
Journal of the National Cancer InstituteDOI
10.1093/jnci/djr079PubMed ID
21483019Type
ArticleLanguage
enISSN
1460-2105ae974a485f413a2113503eed53cd6c53
10.1093/jnci/djr079
Scopus Count
Related articles
- Tamoxifen, mammographic density, and breast cancer prevention.
- Authors: Boyd NF
- Issue date: 2011 May 4
- Tamoxifen and breast density in women at increased risk of breast cancer.
- Authors: Cuzick J, Warwick J, Pinney E, Warren RM, Duffy SW
- Issue date: 2004 Apr 21
- Twenty-year follow-up of the Royal Marsden randomized, double-blinded tamoxifen breast cancer prevention trial.
- Authors: Powles TJ, Ashley S, Tidy A, Smith IE, Dowsett M
- Issue date: 2007 Feb 21
- Long-term results of tamoxifen prophylaxis for breast cancer--96-month follow-up of the randomized IBIS-I trial.
- Authors: Cuzick J, Forbes JF, Sestak I, Cawthorn S, Hamed H, Holli K, Howell A, International Breast Cancer Intervention Study I Investigators.
- Issue date: 2007 Feb 21
- Randomized double-blind 2 x 2 trial of low-dose tamoxifen and fenretinide for breast cancer prevention in high-risk premenopausal women.
- Authors: Decensi A, Robertson C, Guerrieri-Gonzaga A, Serrano D, Cazzaniga M, Mora S, Gulisano M, Johansson H, Galimberti V, Cassano E, Moroni SM, Formelli F, Lien EA, Pelosi G, Johnson KA, Bonanni B
- Issue date: 2009 Aug 10